RT Journal Article
SR Electronic
T1 WITHDRAWN: Application of diagnostic network optimization in Kenya and Nepal to design integrated, sustainable and efficient bacteriology and antimicrobial resistance surveillance networks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.03.22281886
DO 10.1101/2022.11.03.22281886
A1 Brunetti, Marie
A1 Singh, Amit
A1 Chebore, Sheilla
A1 Gyenwali, Deepak
A1 Malou, Nada
A1 Ferreyra, Cecilia
A1 Gompo, Tulsi Ram
A1 Acharya, Jyoti
A1 Rijal, Nisha
A1 Githii, Susan
A1 Wesangula, Evelyn
A1 Albert, Heidi
YR 2023
UL http://medrxiv.org/content/early/2023/12/11/2022.11.03.22281886.abstract
AB The authors have withdrawn this manuscript as it contains data that did not have the proper permissions to be publicly distributed. Therefore, the authors do not wish this work to be cited as a reference for the project. Please refer to the published version under DOI: 10.1371/journal.pgph.0002247. If you have any questions, please contact the corresponding author.Competing Interest StatementHeidi Albert, Marie Brunetti, Cecilia Ferreyra, Deepak Gyenwali and Amit Singh are employed by FIND, the global alliance for diagnostics. Sheilla Chebore and Nada Malou were consultants for FIND during the project. FIND is a not-for-profit foundation that supports the evaluation of publicly prioritized tuberculosis assays and the implementation of WHO-approved (guidance and prequalification) assays using donor grants. FIND has product evaluation agreements with several private sector companies that design diagnostics for tuberculosis and other diseases. These agreements strictly define FIND's independence and neutrality with regard to these private sector companies.Funding StatementThis work was funded by the Department of Health and Social Care’s Fleming Fund using UK aid. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health and Social Care or its Management Agent, Mott MacDonald.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes